Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients

Fig. 4

Disease-free survival and progression-free survival curves in prostate biopsy (cohort #1). a Disease-free survival curves according to standard clinicopathological parameters [prognostic grade group and CAPRA Score], panel #2 and panel #2 plus miR-34b/c promoter methylation levels b Progression-free survival curves according to standard clinicopathological features [prognostic grade group and CAPRA Score] and panel #2 and panel #2 plus miR-34b/c promoter methylation levels 

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us